0001213900-16-014382.txt : 20160620
0001213900-16-014382.hdr.sgml : 20160620
20160620171028
ACCESSION NUMBER: 0001213900-16-014382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160616
FILED AS OF DATE: 20160620
DATE AS OF CHANGE: 20160620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELDIS JEROME B
CENTRAL INDEX KEY: 0001433982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16929
FILM NUMBER: 161722783
MAIL ADDRESS:
STREET 1: 8767 E. VIA DE VENTURA, SUITE 190
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
4
1
f4061616zeldis_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2016-06-16
0
0000812796
SOLIGENIX, INC.
SNGX
0001433982
ZELDIS JEROME B
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
0.74
2016-06-16
4
A
0
40541
0
A
2026-06-15
Common Stock
40541
40541
D
The stock option vests ratably on each of September 16, 2016, December 16, 2016, March 16, 2017 and June 16, 2017.
/s/ Jerome B. Zeldis
2016-06-20